Antares Pharma completes enrollment in Phase 3 clinical trial of Anturol for OAB Antares Pharma, Inc http://dmae.xyz/ . Best line data out of this pivotal trial, which is being conducted under a particular Protocol Assessment from the U.S. Food and Drug Administration , is expected in the 3rd quarter of the full year. An interview with Professor Lesley JonesLenvatinib trial gives hope for thyroid cancer patientsAlport syndrome: an interview with Dr Paul Grint, CMO, Regulus Dr.S. FDA in 2010 2010. We continue to believe that Anturol presents many unique advantages over currently marketed products for the treating OAB.